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INTRODUCTION
Temu kunci or fingerroot (Boesenbergia pandurata Roxb.) is one of Indonesian traditional herbal medicine plant which has a lot of health benefits, such as for mucolytic antitussive medicine, antacids, appetite enhancer, antistomatitis, and galactagogue. A lot of research has been done to determine the health potentials of fingeroot rhizome and essential oil, and it has been proven to have anti-fungal 1,2 anti-bacterial 3, 4 , antiviral 5, 6 , anti-inflammatory 7 , and antioxidant properties 8, 9, 10 . Previous researches that have been done on colon and breast cancer cells showed a promising potential of fingerroot as anti-tumor. 11 This finding is in line with a study by Kamkaen et al., who found that fingerroot extract had cytotoxic properties against laringeal cancer cells (Hep2). 12 The active ingredient contained in fingerroot that is thought to have anti-tumor potentials is flavonoid pinostrobin (5-hidroksi-7-metoksiflavanon) which bioactivities had been widely studied as anti-oxidant 13 , antiviral 14 , and anti-tumor. The anti-tumor effect of pinostrobin had been examined by Le Bail et al. 15 on breast cancer cells. Smolarz et al. studied the effect of pinostrobin on the apoptotic respond of in vitro leukemia cells. 16 The effect of pinostrobin on HeLa cells is not yet known.
METHODS

Study design and subjects
This study is a laboratorium experimental study to compare the anti-cancer potentials of pinostrobin fingerroot based on its cytotoxicity on HeLa cell cultures. HeLa cell cultures were obtained from LPPT Hayati Universitas Gadjah Mada Yogyakarta. Pinostrobin used in this study was isolated from fingerroot rhizome (B. pandurata) by Laboratorium Biologi Farmasi FMIPA Universitas Islam Indonesia. The determination of fingerroot plant was also done by Laboratorium Biologi Farmasi FMIPA UII Yogyakarta
Study Procedure a. Fingerroot preparation and pinostrobin isolation
Temukunci or fingerroot (B. pandurata) used in this study was obtained and processed into powder by Merapi Farma company. The identification of the plant and isolation of pinostrobin was done at Fakultas MIPA Universitas Islam Indonesia.
The dry powder of fingerroot rhizome (400g) was extracted 3 times using n-hexane. The dregs from the extraction process were re-extracted using ethyl acetate 3 times. Then, the extracts were evaporated using rotary evaporator until a thicker extract was gained (20,3g). The outcome of these processes undergo Vacuum Liquid Chromatography (VLC) with stationary phase using silica gel GF254 (Merck) and mobile phase using n-hexan : ethylacetate with various comparison gradient until 10 fractions were gained. Afterward, every fractions were analyzed using Thin-layer Chromatography (TLC) with standard pinostrobin (Sigma-Aldrich) as control. Then, fraction 4 (N-hexan : ethylacetate 35:15) was separated once more using Preparative Thin-layer Chromatography (Prep TLC) until pinostrobin was gained (67 mg). Pinostrobin obtained from the previos processes was analyzed using TLC Densitometry, so it could be confirmed that the isolates was Pinostrobin isolate.
HeLa cell cultures were obtained from Laboratorium Penelitian dan Pengujian Terpadu (LPPT) Hayati Universitas Gadjah Mada.
The cultures were grown on RPMI media and completed with supplementation of penicillinstreptomycin (Penstrep® Sigma-Aldrich), Amphotericin B (Fungizone® Sigma-Aldrich), ceftriaxone 0,1% and bovine serum 10% (SigmaAldrich). Replacement of media was done everyday, while sub-culture was done when the cell compactness in the flask exceed 80%.
b.
Intervention and MTT assay HeLa cells were trypsinized with trypsin 0,25% and then washed with PBS 3 times, and later resuspended in fresh RPMI medium and moved into 96-well plate with density 5 x 103 cell/mL, with volume 200 µL, incubated for 1 day until the cells attached and entered growth phase. Later on, the medium was changed with another medium that had been added with pinostrobin in the concentration of 5, 25, 50, 75, 100 and 250 µg/mL (each concentration was triplicate), and then incubated for 24 hours. After that, the medium was changed again into fresh medium and incubated for 2 x 24 hours.
Afterward, MTT assay was done by: dispose medium, change with 200 µL fresh medium and added 50µL [3-(4,5 dimethyl thiazo-2-yl)-2,5 diphenyltetrazolium bromide] (MTT). Plate was wrapped in aluminum foil, incubated for 4-8 hours. Then, medium and MTT was disposed, the remaining crystal was disolved in 200µL dimethylsufoxide (DMSO). Added glycine buffer 25µL per preparations. Absorbance was read with ELISA reader in 570nm wavelength.
Data Analysis
The collected data was processed so that a greater percentage of cell viability at various pinostrobin concentration were achieved. Analysis was done using one-way ANOVA SPSS ver. 15, while inhibitory concentration (IC 50 ) of pinostrobin was determined by establishing a pinostrobin concentration curve against the precentage of viability.
RESULTS
In this study, MTT assay that was done on HeLa cultures with and without pinostrobin temu kunci or fingerroot, generates result as seen in Table 1 . On the graphic of HeLa cells viability against the addition of Pinostrobin (Figure1), it can be seen that pinostrobin concentration which inhibit 50% (IC 50 ) of cells viability is 250µg/mL.
DISCUSSION
In this study, it was found that the addition of pinostrobin on the culture of HeLa cells can significantly (p = 0,00) reduce the viability of cells. Based on posthoc test with Tukey HSD, significant difference can be seen in pinostrobin concentration 250µg/mL compare to other gradient of concentration, and between concentration 100µg/mL with concentration 5 and 25µg/mL. This result implicate that Pinostrobin has low cytotoxic activity against HeLa cells. The cytotoxic activities are classified into four groups : High (IC50<10 µg/ml), active (IC50>10µg/ ml<50µg/ml), Moderate active (50<IC50<100µg/ ml), and inactive (IC50>100µg/ml). 17 Hence, in this research it can be concluded that the cytotoxic activity of Pinostrobin is inactive.
The result of this research is dissimilar with other researches who also studied the cytotoxic activity of Pinostrobin. Poerwono et al 18 studied its effect on cancer cells SK-BR-3, MCF-7, and PC-3, obtained IC50 against 94,3 µM, 84,9 µM, and 86,7 µM. Sukardiman et al 19 studied its effect on the culture of breast cancer cells, concluded that the anti-cancer effect of Pinostrobin is due to its inhibitory activity on topoisomerase I enzymes which contribute on DNA replication. Advanced research showed that Pinostrobin temu kunci or fingerroot also has apoptotic induction activity against human breast cancer cells T-47D through p53 and bax pathway, as well as inhibition on COX-2 expression in vitro. 20 The difference in findings between this research and previous researches might be due to a different response or sensitivity of HeLa cells against pinostrobin, but further research is needed to confirm this assumption.
CONCLUSION
Pinostrobin did not show any cytotoxic activity against the culture of HeLa cells. 
